(Q41734805)

English

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

scientific article published on July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 October 2017

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells (English)

1 reference

Europe PubMed Central

8 October 2017

phosphorylation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wakino S

1

1 reference

Europe PubMed Central

8 October 2017

Kintscher U

2

1 reference

Europe PubMed Central

8 October 2017

Kim S

3

1 reference

Europe PubMed Central

8 October 2017

Yin F

4

1 reference

Europe PubMed Central

8 October 2017

Hsueh WA

5

1 reference

Europe PubMed Central

8 October 2017

Law RE

6

1 reference

Europe PubMed Central

8 October 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

8 October 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

8 October 2017

275

1 reference

Europe PubMed Central

8 October 2017

22435-22441

1 reference

Europe PubMed Central

8 October 2017

29

1 reference

Europe PubMed Central

8 October 2017

Cell biology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Insulin signaling in the arterial wall

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Cancer cell cycles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Role of the Rb/E2F pathway in cell growth control

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

E2F and cell proliferation: a world turned upside down

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

An analysis of Mek1 signaling in cell proliferation and transformation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Protein lipidation in cell signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

New functional activities for the p21 family of CDK inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M910452199

21 January 2018

Identifiers

10.1074/JBC.M910452199

1 reference

Europe PubMed Central

8 October 2017

release_z5w6cz3f35d7tcdcgzfty2xxxy

1 reference

https://api.fatcat.wiki/v0/release/z5w6cz3f35d7tcdcgzfty2xxxy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

8 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41734805&oldid=1926681136"